High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.0M
$1,024,660
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-04-01 | $65,228 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Ridloff Elena
• Director
10b5-1 SellΔOwn -73.9%
2026-04-01
$289,662
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -73.9%
|
2026-04-01 | $289,662 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-04-01 | $103,260 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-03-31 | $104,932 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-31 | $631,739 | S | Form 4 |